Humanigen Files Ch. 11 Plan Disclosures

By Emily Lever · April 15, 2024, 7:57 PM EDT

Bankrupt biopharma company Humanigen Inc. has filed a proposed Chapter 11 plan and disclosure statement in Delaware court that calls for the payment in full of secured and priority claims, while...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Plan
Motion

Case Information

Case Title

Humanigen, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

January 03, 2024

Recent Articles By Emily

November 05, 2024
The Story Behind Vaccine Maker Gritstone's Ch. 11
October 10, 2024
Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt
August 20, 2024
Steward Health, Landlord Spar Over Ch. 11 Hospital Sales
July 03, 2024
Steward Health Downfall Prompts Calls For Tighter Regs
May 30, 2024
Cue Health Spiraled Into Ch. 7 After FDA Nixed COVID Tests
April 25, 2024
Benefytt Successor Pursues Del.'s Bankruptcy Alternative
April 22, 2024
Petersen Health Shouldn't Get LLCs Back, Creditor Says
April 16, 2024
Bankrupt Breast Implant Co. Submits Ch. 11 Plan Disclosures
April 04, 2024
Meet The Attys In Acorda Therapeutics' Ch. 11
February 20, 2024
US Trustee Wants Sorrento Ch. 11 Tossed Or Relocated